Details for: BCL3

Gene ID: 602

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: BCL3

Ensembl ID: ENSG00000069399

Description: BCL3 transcription coactivator

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • duct epithelial cell CL0000068
    CSI 16.9
    rCSI 24.72%
    PRS 35.81
  • immature B cell CL0000816
    CSI 12.64
    rCSI 9.39%
    PRS 45.94
  • dendritic cell, human CL0001056
    CSI 12.25
    rCSI 18.82%
    PRS 39.45
  • common myeloid progenitor CL0000049
    CSI 11.86
    rCSI 9.59%
    PRS 33.9
  • alveolar adventitial fibroblast CL4028006
    CSI 11.2
    rCSI 17.69%
    PRS 34.25
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 8.9
    rCSI 11.66%
    PRS 45.68
  • mucous neck cell CL0000651
    CSI 8.65
    rCSI 12.47%
    PRS 47.41
  • mature B cell CL0000785
    CSI 8.09
    rCSI 7.03%
    PRS 41.55
  • vascular associated smooth muscle cell CL0000359
    CSI 7.88
    rCSI 25.56%
    PRS 37.52
  • retinal blood vessel endothelial cell CL0002585
    CSI 7.84
    rCSI 12.52%
    PRS 36.55
  • granulocyte CL0000094
    CSI 7.32
    rCSI 11.19%
    PRS 41.9
  • neutrophil CL0000775
    CSI 6.95
    rCSI 38.87%
    PRS 48.46
  • lung pericyte CL0009089
    CSI 6.91
    rCSI 18.24%
    PRS 39.66
  • pulmonary capillary endothelial cell CL4028001
    CSI 5.94
    rCSI 11.32%
    PRS 49.75
  • goblet cell CL0000160
    CSI 5.6
    rCSI 5.29%
    PRS 34.72
  • cardiac endothelial cell CL0010008
    CSI 5.6
    rCSI 22.58%
    PRS 32.58
  • extravillous trophoblast CL0008036
    CSI 5.08
    rCSI 6.29%
    PRS 30.02
  • basal cell of prostate epithelium CL0002341
    CSI 4.6
    rCSI 13.31%
    PRS 55.03
  • CD4-positive helper T cell CL0000492
    CSI 3.86
    rCSI 2.92%
    PRS 44.48
  • Langerhans cell CL0000453
    CSI 3.62
    rCSI 5.53%
    PRS 51.13
  • pulmonary artery endothelial cell CL1001568
    CSI 3.46
    rCSI 4.71%
    PRS 46.21
  • mononuclear phagocyte CL0000113
    CSI 3.43
    rCSI 7.54%
    PRS 37.35
  • acinar cell CL0000622
    CSI 3.25
    rCSI 4.76%
    PRS 43.14
  • colon epithelial cell CL0011108
    CSI 3.05
    rCSI 3.2%
    PRS 31.39
  • epithelial cell of lung CL0000082
    CSI 2.83
    rCSI 2.34%
    PRS 32.09
  • conjunctival epithelial cell CL1000432
    CSI 2.71
    rCSI 4.14%
    PRS 33.89
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.62
    rCSI 2.27%
    PRS 37.07
  • T-helper 17 cell CL0000899
    CSI 2.56
    rCSI 2.04%
    PRS 54.29
  • Kupffer cell CL0000091
    CSI 2.45
    rCSI 5.61%
    PRS 33.15
  • midzonal region hepatocyte CL0019028
    CSI 2.37
    rCSI 5.56%
    PRS 44.03
  • myofibroblast cell CL0000186
    CSI 2.28
    rCSI 3.16%
    PRS 40.39
  • early lymphoid progenitor CL0000936
    CSI 2.26
    rCSI 1.99%
    PRS 38.15
  • secretory cell CL0000151
    CSI 2.24
    rCSI 2.34%
    PRS 34.25
  • alternatively activated macrophage CL0000890
    CSI 2.24
    rCSI 2.81%
    PRS 46.71
  • foveolar cell of stomach CL0002179
    CSI 2.17
    rCSI 4.63%
    PRS 48.42
  • squamous epithelial cell CL0000076
    CSI 2.16
    rCSI 5.13%
    PRS 39.29
  • perivascular cell CL4033054
    CSI 2.16
    rCSI 2.95%
    PRS 37.55
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 2.15
    rCSI 4.29%
    PRS 51.14
  • epithelial cell of lower respiratory tract CL0002632
    CSI 2.15
    rCSI 1.67%
    PRS 33.23
  • stem cell CL0000034
    CSI 2.13
    rCSI 2.05%
    PRS 25.89
  • group 3 innate lymphoid cell CL0001071
    CSI 2.12
    rCSI 1.6%
    PRS 36.13
  • intrahepatic cholangiocyte CL0002538
    CSI 2.11
    rCSI 5.05%
    PRS 51.25
  • fibroblast of lung CL0002553
    CSI 2.08
    rCSI 1.93%
    PRS 33.43
  • luminal epithelial cell of mammary gland CL0002326
    CSI 2
    rCSI 3.64%
    PRS 48.78
  • bronchus fibroblast of lung CL2000093
    CSI 1.97
    rCSI 1.6%
    PRS 34.52
  • small intestine goblet cell CL1000495
    CSI 1.91
    rCSI 4.18%
    PRS 43
  • multi-ciliated epithelial cell CL0005012
    CSI 1.84
    rCSI 1.83%
    PRS 28.92
  • intestine goblet cell CL0019031
    CSI 1.83
    rCSI 1.62%
    PRS 33.2
  • precursor B cell CL0000817
    CSI 1.8
    rCSI 1.58%
    PRS 42.74
  • pulmonary ionocyte CL0017000
    CSI 1.8
    rCSI 2.19%
    PRS 40.56
  • keratinocyte CL0000312
    CSI 1.78
    rCSI 1.49%
    PRS 38.41
  • alpha-beta T cell CL0000789
    CSI 1.75
    rCSI 2.05%
    PRS 46.7
  • periportal region hepatocyte CL0019026
    CSI 1.72
    rCSI 6.7%
    PRS 43.38
  • plasmacytoid dendritic cell, human CL0001058
    CSI 1.72
    rCSI 1.2%
    PRS 35.27
  • T follicular helper cell CL0002038
    CSI 1.71
    rCSI 1.28%
    PRS 47.68
  • respiratory hillock cell CL4030023
    CSI 1.7
    rCSI 3.04%
    PRS 49.51
  • adventitial cell CL0002503
    CSI 1.7
    rCSI 4.06%
    PRS 45.35
  • respiratory basal cell CL0002633
    CSI 1.66
    rCSI 1.72%
    PRS 38.95
  • elicited macrophage CL0000861
    CSI 1.65
    rCSI 1.51%
    PRS 39.61
  • CD14-positive monocyte CL0001054
    CSI 1.64
    rCSI 2.04%
    PRS 44.47
  • club cell CL0000158
    CSI 1.63
    rCSI 2.38%
    PRS 35.19
  • lung ciliated cell CL1000271
    CSI 1.6
    rCSI 1.85%
    PRS 25.54
  • blood vessel endothelial cell CL0000071
    CSI 1.59
    rCSI 3.29%
    PRS 32.75
  • lung secretory cell CL1000272
    CSI 1.54
    rCSI 3.82%
    PRS 31.88
  • transit amplifying cell CL0009010
    CSI 1.53
    rCSI 2.34%
    PRS 49.8
  • colonocyte CL1000347
    CSI 1.53
    rCSI 2.19%
    PRS 41.46
  • melanocyte of skin CL1000458
    CSI 1.51
    rCSI 2.06%
    PRS 18.19
  • pancreatic acinar cell CL0002064
    CSI 1.5
    rCSI 1.99%
    PRS 37.12
  • BEST4+ enteroycte CL4030026
    CSI 1.48
    rCSI 1.85%
    PRS 35.92
  • skin fibroblast CL0002620
    CSI 1.46
    rCSI 1.26%
    PRS 43.74
  • enterocyte CL0000584
    CSI 1.45
    rCSI 2.34%
    PRS 44.2
  • common lymphoid progenitor CL0000051
    CSI 1.44
    rCSI 1.93%
    PRS 55.8
  • glandular epithelial cell CL0000150
    CSI 1.42
    rCSI 3.73%
    PRS 56.69
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.42
    rCSI 1.71%
    PRS 39.99
  • vein endothelial cell of respiratory system CL4033008
    CSI 1.41
    rCSI 9.7%
    PRS 54.1
  • common dendritic progenitor CL0001029
    CSI 1.36
    rCSI 1.71%
    PRS 42.19
  • ionocyte CL0005006
    CSI 1.35
    rCSI 1.45%
    PRS 31.49
  • nasal mucosa goblet cell CL0002480
    CSI 1.35
    rCSI 1.57%
    PRS 44.34
  • hepatocyte CL0000182
    CSI 1.3
    rCSI 2.34%
    PRS 31.91
  • fallopian tube secretory epithelial cell CL4030006
    CSI 1.3
    rCSI 1.25%
    PRS 34.46
  • germinal center B cell CL0000844
    CSI 1.28
    rCSI 3.82%
    PRS 58.52
  • centrilobular region hepatocyte CL0019029
    CSI 1.25
    rCSI 3.26%
    PRS 44.41
  • M cell of gut CL0000682
    CSI 1.25
    rCSI 1.32%
    PRS 49.44
  • respiratory suprabasal cell CL4033048
    CSI 1.24
    rCSI 1.58%
    PRS 38.04
  • tracheal goblet cell CL1000329
    CSI 1.23
    rCSI 2.68%
    PRS 54.42
  • myeloid dendritic cell CL0000782
    CSI 1.19
    rCSI 1.73%
    PRS 48.42
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 1.16
    rCSI 3.13%
    PRS 42.15
  • tracheobronchial smooth muscle cell CL0019019
    CSI 1.16
    rCSI 2.05%
    PRS 41.77
  • lung macrophage CL1001603
    CSI 1.07
    rCSI 2.4%
    PRS 39.03
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.07
    rCSI 1.82%
    PRS 54.69
  • bronchial goblet cell CL1000312
    CSI 1.06
    rCSI 4.22%
    PRS 56.44
  • intermediate monocyte CL0002393
    CSI 1.04
    rCSI 1.57%
    PRS 34.76
  • myeloid dendritic cell, human CL0001057
    CSI 0.99
    rCSI 5.58%
    PRS 69.15
  • helper T cell CL0000912
    CSI 0.99
    rCSI 1.4%
    PRS 43.41
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 0.95
    rCSI 1.15%
    PRS 34.35
  • promonocyte CL0000559
    CSI 0.89
    rCSI 1.53%
    PRS 42.62
  • pancreatic ductal cell CL0002079
    CSI 0.86
    rCSI 1.67%
    PRS 34.94
  • luminal cell of prostate epithelium CL0002340
    CSI 0.86
    rCSI 4.6%
    PRS 50.15
  • paneth cell of epithelium of small intestine CL1000343
    CSI 0.79
    rCSI 2.22%
    PRS 48.25
  • endothelial cell of uterus CL0009095
    CSI 0.76
    rCSI 5.59%
    PRS 63.63
  • tracheobronchial serous cell CL0019001
    CSI 0.3
    rCSI 1.1%
    PRS 51.3%
  • Hofbauer cell CL3000001
    CSI 0.3
    rCSI 0.7%
    PRS 42.2%
  • basal cell of epithelium of trachea CL1000348
    CSI 0.4
    rCSI 3.0%
    PRS 62.6%
  • deuterosomal cell CL4033044
    CSI 0.6
    rCSI 2.0%
    PRS 45.2%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 0.6
    rCSI 1.8%
    PRS 36.5%
  • enteroglial cell CL4040002
    CSI 0.6
    rCSI 3.3%
    PRS 44.7%
  • mammary gland epithelial cell CL0002327
    CSI 0.6
    rCSI 2.2%
    PRS 50.0%
  • corneal epithelial cell CL0000575
    CSI 0.7
    rCSI 2.0%
    PRS 51.6%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.7
    rCSI 3.5%
    PRS 43.0%
  • type EC enteroendocrine cell CL0000577
    CSI 0.7
    rCSI 2.6%
    PRS 47.8%
  • endothelial cell of uterus CL0009095
    CSI 0.8
    rCSI 5.6%
    PRS 63.6%
  • paneth cell of epithelium of small intestine CL1000343
    CSI 0.8
    rCSI 2.2%
    PRS 48.3%
  • luminal cell of prostate epithelium CL0002340
    CSI 0.9
    rCSI 4.6%
    PRS 50.2%
  • pancreatic ductal cell CL0002079
    CSI 0.9
    rCSI 1.7%
    PRS 34.9%
  • promonocyte CL0000559
    CSI 0.9
    rCSI 1.5%
    PRS 42.6%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 1.0
    rCSI 1.2%
    PRS 34.4%
  • helper T cell CL0000912
    CSI 1.0
    rCSI 1.4%
    PRS 43.4%
  • myeloid dendritic cell, human CL0001057
    CSI 1.0
    rCSI 5.6%
    PRS 69.2%
  • intermediate monocyte CL0002393
    CSI 1.0
    rCSI 1.6%
    PRS 34.8%
  • bronchial goblet cell CL1000312
    CSI 1.1
    rCSI 4.2%
    PRS 56.4%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.1
    rCSI 1.8%
    PRS 54.7%
  • lung macrophage CL1001603
    CSI 1.1
    rCSI 2.4%
    PRS 39.0%
  • tracheobronchial smooth muscle cell CL0019019
    CSI 1.2
    rCSI 2.1%
    PRS 41.8%
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 1.2
    rCSI 3.1%
    PRS 42.2%
  • myeloid dendritic cell CL0000782
    CSI 1.2
    rCSI 1.7%
    PRS 48.4%
  • tracheal goblet cell CL1000329
    CSI 1.2
    rCSI 2.7%
    PRS 54.4%
  • respiratory suprabasal cell CL4033048
    CSI 1.2
    rCSI 1.6%
    PRS 38.0%
  • M cell of gut CL0000682
    CSI 1.3
    rCSI 1.3%
    PRS 49.4%
  • centrilobular region hepatocyte CL0019029
    CSI 1.3
    rCSI 3.3%
    PRS 44.4%
  • germinal center B cell CL0000844
    CSI 1.3
    rCSI 3.8%
    PRS 58.5%
  • fallopian tube secretory epithelial cell CL4030006
    CSI 1.3
    rCSI 1.3%
    PRS 34.5%
  • hepatocyte CL0000182
    CSI 1.3
    rCSI 2.3%
    PRS 31.9%
  • nasal mucosa goblet cell CL0002480
    CSI 1.4
    rCSI 1.6%
    PRS 44.3%
  • ionocyte CL0005006
    CSI 1.4
    rCSI 1.5%
    PRS 31.5%
  • common dendritic progenitor CL0001029
    CSI 1.4
    rCSI 1.7%
    PRS 42.2%
  • vein endothelial cell of respiratory system CL4033008
    CSI 1.4
    rCSI 9.7%
    PRS 54.1%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.4
    rCSI 1.7%
    PRS 40.0%
  • glandular epithelial cell CL0000150
    CSI 1.4
    rCSI 3.7%
    PRS 56.7%
  • common lymphoid progenitor CL0000051
    CSI 1.4
    rCSI 1.9%
    PRS 55.8%
  • enterocyte CL0000584
    CSI 1.5
    rCSI 2.3%
    PRS 44.2%
  • skin fibroblast CL0002620
    CSI 1.5
    rCSI 1.3%
    PRS 43.7%
  • BEST4+ enteroycte CL4030026
    CSI 1.5
    rCSI 1.9%
    PRS 35.9%
  • pancreatic acinar cell CL0002064
    CSI 1.5
    rCSI 2.0%
    PRS 37.1%
  • melanocyte of skin CL1000458
    CSI 1.5
    rCSI 2.1%
    PRS 18.2%
  • colonocyte CL1000347
    CSI 1.5
    rCSI 2.2%
    PRS 41.5%
  • transit amplifying cell CL0009010
    CSI 1.5
    rCSI 2.3%
    PRS 49.8%
  • lung secretory cell CL1000272
    CSI 1.5
    rCSI 3.8%
    PRS 31.9%
  • blood vessel endothelial cell CL0000071
    CSI 1.6
    rCSI 3.3%
    PRS 32.8%
  • lung ciliated cell CL1000271
    CSI 1.6
    rCSI 1.9%
    PRS 25.5%
  • club cell CL0000158
    CSI 1.6
    rCSI 2.4%
    PRS 35.2%
  • CD14-positive monocyte CL0001054
    CSI 1.6
    rCSI 2.0%
    PRS 44.5%
  • elicited macrophage CL0000861
    CSI 1.7
    rCSI 1.5%
    PRS 39.6%
  • respiratory basal cell CL0002633
    CSI 1.7
    rCSI 1.7%
    PRS 39.0%
  • adventitial cell CL0002503
    CSI 1.7
    rCSI 4.1%
    PRS 45.4%
  • respiratory hillock cell CL4030023
    CSI 1.7
    rCSI 3.0%
    PRS 49.5%
  • T follicular helper cell CL0002038
    CSI 1.7
    rCSI 1.3%
    PRS 47.7%
  • plasmacytoid dendritic cell, human CL0001058
    CSI 1.7
    rCSI 1.2%
    PRS 35.3%
  • periportal region hepatocyte CL0019026
    CSI 1.7
    rCSI 6.7%
    PRS 43.4%
  • alpha-beta T cell CL0000789
    CSI 1.8
    rCSI 2.1%
    PRS 46.7%
  • keratinocyte CL0000312
    CSI 1.8
    rCSI 1.5%
    PRS 38.4%
  • pulmonary ionocyte CL0017000
    CSI 1.8
    rCSI 2.2%
    PRS 40.6%
  • precursor B cell CL0000817
    CSI 1.8
    rCSI 1.6%
    PRS 42.7%
  • intestine goblet cell CL0019031
    CSI 1.8
    rCSI 1.6%
    PRS 33.2%
  • multi-ciliated epithelial cell CL0005012
    CSI 1.8
    rCSI 1.8%
    PRS 28.9%
  • small intestine goblet cell CL1000495
    CSI 1.9
    rCSI 4.2%
    PRS 43.0%
  • bronchus fibroblast of lung CL2000093
    CSI 2.0
    rCSI 1.6%
    PRS 34.5%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 2.0
    rCSI 3.6%
    PRS 48.8%
  • fibroblast of lung CL0002553
    CSI 2.1
    rCSI 1.9%
    PRS 33.4%
  • intrahepatic cholangiocyte CL0002538
    CSI 2.1
    rCSI 5.1%
    PRS 51.3%
  • group 3 innate lymphoid cell CL0001071
    CSI 2.1
    rCSI 1.6%
    PRS 36.1%
  • stem cell CL0000034
    CSI 2.1
    rCSI 2.1%
    PRS 25.9%
  • epithelial cell of lower respiratory tract CL0002632
    CSI 2.2
    rCSI 1.7%
    PRS 33.2%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 2.2
    rCSI 4.3%
    PRS 51.1%
  • perivascular cell CL4033054
    CSI 2.2
    rCSI 3.0%
    PRS 37.6%
  • squamous epithelial cell CL0000076
    CSI 2.2
    rCSI 5.1%
    PRS 39.3%
  • foveolar cell of stomach CL0002179
    CSI 2.2
    rCSI 4.6%
    PRS 48.4%
  • alternatively activated macrophage CL0000890
    CSI 2.2
    rCSI 2.8%
    PRS 46.7%
  • secretory cell CL0000151
    CSI 2.2
    rCSI 2.3%
    PRS 34.3%
  • early lymphoid progenitor CL0000936
    CSI 2.3
    rCSI 2.0%
    PRS 38.2%
  • myofibroblast cell CL0000186
    CSI 2.3
    rCSI 3.2%
    PRS 40.4%
  • midzonal region hepatocyte CL0019028
    CSI 2.4
    rCSI 5.6%
    PRS 44.0%
  • Kupffer cell CL0000091
    CSI 2.5
    rCSI 5.6%
    PRS 33.2%
  • T-helper 17 cell CL0000899
    CSI 2.6
    rCSI 2.0%
    PRS 54.3%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.6
    rCSI 2.3%
    PRS 37.1%
  • conjunctival epithelial cell CL1000432
    CSI 2.7
    rCSI 4.1%
    PRS 33.9%
  • epithelial cell of lung CL0000082
    CSI 2.8
    rCSI 2.3%
    PRS 32.1%
  • colon epithelial cell CL0011108
    CSI 3.1
    rCSI 3.2%
    PRS 31.4%
  • acinar cell CL0000622
    CSI 3.3
    rCSI 4.8%
    PRS 43.1%
  • mononuclear phagocyte CL0000113
    CSI 3.4
    rCSI 7.5%
    PRS 37.4%
  • pulmonary artery endothelial cell CL1001568
    CSI 3.5
    rCSI 4.7%
    PRS 46.2%
  • Langerhans cell CL0000453
    CSI 3.6
    rCSI 5.5%
    PRS 51.1%
  • CD4-positive helper T cell CL0000492
    CSI 3.9
    rCSI 2.9%
    PRS 44.5%
  • basal cell of prostate epithelium CL0002341
    CSI 4.6
    rCSI 13.3%
    PRS 55.0%
  • extravillous trophoblast CL0008036
    CSI 5.1
    rCSI 6.3%
    PRS 30.0%
  • cardiac endothelial cell CL0010008
    CSI 5.6
    rCSI 22.6%
    PRS 32.6%
  • goblet cell CL0000160
    CSI 5.6
    rCSI 5.3%
    PRS 34.7%
  • pulmonary capillary endothelial cell CL4028001
    CSI 5.9
    rCSI 11.3%
    PRS 49.8%
  • lung pericyte CL0009089
    CSI 6.9
    rCSI 18.2%
    PRS 39.7%
  • neutrophil CL0000775
    CSI 7.0
    rCSI 38.9%
    PRS 48.5%
  • granulocyte CL0000094
    CSI 7.3
    rCSI 11.2%
    PRS 41.9%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [BCL3](/details-gene/602) (B-cell lymphoma 3) is a protein-coding gene located on chromosome 19q13.32 that functions as a transcriptional coactivator. It is a member of the IκB protein family, which are known inhibitors of NF-κB transcription factors. However, unlike typical IκB proteins, [BCL3](/details-gene/602) can act as both a positive and negative regulator of transcription, primarily by associating with NF-κB p50 or p52 homodimers ([Link](https://doi.org/10.1016/0092-8674(93)90401-b)). Initially identified as a proto-oncogene involved in B-cell malignancies ([Link](https://doi.org/10.1016/0092-8674(90)90347-h); [109560](https://omim.org/entry/109560)), its expression profile suggests a broad role in both the immune system and non-hematopoietic tissues. **Overall**, it shows high significance in immune cells such as [immature B cell](/details-cell/CL0000816) and [dendritic cell, human](/details-cell/CL0001056), consistent with its established role in humoral immunity and inflammation. Strikingly, it also demonstrates the highest significance in [duct epithelial cell](/details-cell/CL0000068), indicating a potentially critical but less-characterized function in epithelial biology. ## Cellular Roles and Expression Landscape The expression profile of [BCL3](/details-gene/602) reveals its importance across a diverse range of cell types, spanning hematopoietic, epithelial, and mesenchymal lineages. **Overall**, its significance is most pronounced in immune cell populations, which aligns with its function as a modulator of NF-κB signaling. It is a key marker in both lymphoid and myeloid compartments, including [immature B cell](/details-cell/CL0000816), [mature B cell](/details-cell/CL0000785), [dendritic cell, human](/details-cell/CL0001056), [common myeloid progenitor](/details-cell/CL0000049), [CD14-positive, CD16-positive monocyte](/details-cell/CL0002397), and [neutrophil](/details-cell/CL0000775). This pattern suggests a fundamental role in immune cell development, activation, and response to stimuli. Beyond the immune system, [BCL3](/details-gene/602) shows prominent significance in several non-hematopoietic cell types. Its highest calculated significance is in [duct epithelial cell](/details-cell/CL0000068), with notable expression also observed in [mucous neck cell](/details-cell/CL0000651) and [goblet cell](/details-cell/CL0000160). This suggests an important, perhaps underappreciated, role in epithelial barrier function, secretion, or inflammatory responses at mucosal surfaces. Furthermore, its expression in stromal and endothelial cells, such as [alveolar adventitial fibroblast](/details-cell/CL4028006), [vascular associated smooth muscle cell](/details-cell/CL0000359), and [retinal blood vessel endothelial cell](/details-cell/CL0002585), points to potential involvement in tissue architecture, angiogenesis, and vascular inflammation. ## Pathways and Molecular Function Functional annotation corroborates the role of [BCL3](/details-gene/602) as a key regulator of immunity and transcription. Its molecular function is primarily defined by its ability to bind other proteins ([GO:0005515](https://www.ebi.ac.uk/QuickGO/term/GO:0005515)) and DNA-binding transcription factors ([GO:0140297](https://www.ebi.ac.uk/QuickGO/term/GO:0140297)), acting as a [transcription coactivator](/details-go/GO:0003713) or [corepressor](/details-go/GO:0003714). This dual regulatory capacity is central to its biological activity. The gene is deeply integrated into NF-κB signaling pathways, participating in both [canonical](/details-go/GO:0007249) and [non-canonical](/details-go/GO:1901222) signal transduction. It is known to negatively regulate NF-κB activity ([GO:0032088](https://www.ebi.ac.uk/QuickGO/term/GO:0032088)) and modulate the production of inflammatory cytokines like IL-8 ([GO:0032717](https://www.ebi.ac.uk/QuickGO/term/GO:0032717)) and TNF ([GO:0032720](https://www.ebi.ac.uk/QuickGO/term/GO:0032720)), while positively regulating IL-10 ([GO:0032733](https://www.ebi.ac.uk/QuickGO/term/GO:0032733)). These molecular functions translate into its involvement in numerous biological processes. A major theme is the regulation of immunity, including [antimicrobial humoral response](/details-go/GO:0019730), [defense response to bacterium](/details-go/GO:0042742), and the differentiation of B cells, such as [marginal zone b cell differentiation](/details-go/GO:0002315). Consistent with its role in lymphoid malignancies, [BCL3](/details-gene/602) is also a critical regulator of the [apoptotic process](/details-go/GO:0042981), often exerting a negative regulatory effect ([GO:0043066](https://www.ebi.ac.uk/QuickGO/term/GO:0043066)), and is implicated in the [DNA damage response](/details-go/GO:0006974). Its localization within the cell is dynamic, being found in both the [cytoplasm](/details-go/GO:0005737) and the [nucleus](/details-go/GO:0005634), where it forms complexes with transcription factors to exert its effects. ## Research Directions The diverse expression pattern of [BCL3](/details-gene/602), particularly its high significance in cell types outside of the B-lymphocyte lineage, opens several avenues for future investigation. Its proto-oncogenic nature and central role in inflammation position it as a gene of significant clinical interest. Based on the available data, several testable hypotheses can be proposed: 1. Given its top significance in [duct epithelial cell](/details-cell/CL0000068), [BCL3](/details-gene/602) may be a master regulator of epithelial cell response to inflammatory or damage signals, controlling the balance between pro-inflammatory signaling and tissue repair. Its dysregulation in these cells could contribute to chronic inflammatory diseases or epithelial-derived cancers. 2. The high significance of [BCL3](/details-gene/602) in [common myeloid progenitor](/details-cell/CL0000049) and its known role in B-cell development suggests it acts as a critical fate-determining factor during hematopoiesis. It may function at key checkpoints to regulate the lineage commitment of progenitors toward either myeloid or lymphoid paths by modulating transcriptional programs and cell survival. A key experiment to test the first hypothesis could involve the following: * **Experimental Approach:** Utilize 3D organoid cultures derived from primary human ductal epithelium (e.g., pancreatic or salivary gland). Perform a CRISPR-Cas9-mediated knockout of [BCL3](/details-gene/602) in these organoids. The knockout and wild-type organoids would then be challenged with inflammatory stimuli such as TNF-α or bacterial lipopolysaccharide (LPS). The impact would be assessed using single-cell RNA sequencing to delineate changes in epithelial cell states and inflammatory gene expression, complemented by functional assays measuring cytokine secretion (ELISA) and epithelial barrier integrity (transepithelial electrical resistance). **Therapeutic Potential:** [BCL3](/details-gene/602) is a compelling therapeutic target, primarily for inhibition. As a proto-oncogene whose overexpression is linked to B-cell lymphomas and other cancers, developing strategies to block its function is a rational approach. Because it functions as a transcriptional coactivator by binding to protein partners, its protein-protein interaction surfaces are attractive targets for small molecule inhibitors. However, its broad expression across immune, epithelial, and stromal cells suggests that systemic inhibition could lead to significant off-target effects, particularly by disrupting normal immune function or tissue homeostasis. Therefore, targeted therapies, such as antibody-drug conjugates for BCL3-overexpressing cancer cells or context-specific inhibitors, may be required to achieve a favorable therapeutic window.

Genular Protein ID: 961947900

Symbol: BCL3_HUMAN

Name: B-cell lymphoma 3 protein

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 2180580

Title: The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.

PubMed ID: 2180580

DOI: 10.1016/0092-8674(90)90347-h

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 7896265

Title: Genomic structure of the candidate proto-oncogene BCL3.

PubMed ID: 7896265

DOI: 10.1006/geno.1994.1588

PubMed ID: 8453667

Title: The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.

PubMed ID: 8453667

DOI: 10.1016/0092-8674(93)90401-b

PubMed ID: 10469655

Title: NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.

PubMed ID: 10469655

DOI: 10.1093/emboj/18.17.4766

PubMed ID: 10362352

Title: The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.

PubMed ID: 10362352

DOI: 10.1038/sj.onc.1202717

PubMed ID: 12730195

Title: Identification and characterization of BCL-3-binding protein: implications for transcription and DNA repair or recombination.

PubMed ID: 12730195

DOI: 10.1074/jbc.m303518200

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 11707390

Title: Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.

PubMed ID: 11707390

DOI: 10.1093/emboj/20.22.6180

PubMed ID: 15469820

Title: GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity.

PubMed ID: 15469820

DOI: 10.1016/j.molcel.2004.09.004

Sequence Information:

  • Length: 454
  • Mass: 47584
  • Checksum: 385F5320DB72C0E0
  • Sequence:
  • MPRCPAGAMD EGPVDLRTRP KAAGLPGAAL PLRKRPLRAP SPEPAAPRGA AGLVVPLDPL 
    RGGCDLPAVP GPPHGLARPE ALYYPGALLP LYPTRAMGSP FPLVNLPTPL YPMMCPMEHP 
    LSADIAMATR ADEDGDTPLH IAVVQGNLPA VHRLVNLFQQ GGRELDIYNN LRQTPLHLAV 
    ITTLPSVVRL LVTAGASPMA LDRHGQTAAH LACEHRSPTC LRALLDSAAP GTLDLEARNY 
    DGLTALHVAV NTECQETVQL LLERGADIDA VDIKSGRSPL IHAVENNSLS MVQLLLQHGA 
    NVNAQMYSGS SALHSASGRG LLPLVRTLVR SGADSSLKNC HNDTPLMVAR SRRVIDILRG 
    KATRPASTSQ PDPSPDRSAN TSPESSSRLS SNGLLSASPS SSPSQSPPRD PPGFPMAPPN 
    FFLPSPSPPA FLPFAGVLRG PGRPVPPSPA PGGS

Genular Protein ID: 84958022

Symbol: B7Z3N9_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 356
  • Mass: 38515
  • Checksum: 89BE4A384BF065AD
  • Sequence:
  • MEEGRERNRS WPPAECQSLP RVRLFTPTKE ETAQRGEVFG QGHPARALLP LYPTRAMGSP 
    FPLVNLPTPL YPMMCPMEHP LSADIAMATR ADEDGDTPLH IAVVQGNLPA VHRLVNLFQQ 
    GGRELDIYNN LRQTPLHLAV ITTLPSVVRL LVTAGASPMA LDRHGQTAAH LACEHRSPTC 
    LRALLDSAAP GTLDLEARNY DGLTALHVAV NTECQETVQL LLERGADIDA VDIKSGRSPL 
    IHAVENNSLS MVQLLLQHGA NVNAQMYSGS SALHSASGRG LLPLVRTLVR SGADSSLKNC 
    HNDTPLMVAR SRRVSRGSCG HAPCTRVSAG WLQASVPERR GVRVSVPLRG GEWVSL